SB5
To Add The Criminal Offense Of Prescription Drug Harm Or Homicide.
Last Action (May 5, 2025): Died in Senate Committee at Sine Die adjournment.
Sponsors
AI-Generated Summary
Senate Bill 5 creates a new criminal offense in Arkansas titled 'prescription drug harm or homicide.' The bill targets executive officers of pharmaceutical companies who knowingly withhold information regarding the dangerous effects of a prescription drug that subsequently causes serious physical injury or death to a patient in the state. The offense is classified as an unclassified felony punishable by imprisonment ranging from one year to life. Additionally, the bill establishes a 'Prescription Drug Harm or Homicide Offense Fund' to provide financial support for the prosecution of these cases. The act includes a sunset provision, meaning the law and the fund will expire on December 31, 2026.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries of this bill would be individuals and families affected by prescription drugs that have been marketed with concealed safety risks, as the law provides a pathway for criminal accountability for corporate executives. Additionally, the bill provides state prosecutors with a dedicated fund to help cover the costs and resources required to pursue complex litigation against pharmaceutical companies.
Who Might Suffer?
The primary group negatively impacted by this legislation would be executive officers of pharmaceutical companies, who could face criminal charges and significant prison sentences if found to have knowingly withheld safety information. Pharmaceutical companies as entities may also face increased legal, financial, and regulatory risk, potentially influencing their operational strategies, research and development priorities, or corporate governance practices within the state.
Get Notified
Receive an email when this bill's status changes.